Saturday, July 4, 2026

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

Will Putin Step Up His Arms Deal with North Korea?

As Russian President Vladimir Putin's visit to...

Why Dog Shoes Might Be Hurting Your Pup’s Paws and Joints

Experts warn that improperly fitted dog shoes can harm joint health, urging owners to prioritize barefoot walking for their pets.

Tag: QUADESSY

Classys Unveils Aggressive Growth Strategy at AAD 2026: What’s Next for the U.S. Market?

Classys reveals its growth strategy for the U.S. market at AAD 2026, showcasing innovative products and emphasizing clinical efficacy.

Top News

- Our Sponsors Ad -

Follow us